New Atrial Fibrillation/Flutter Pathway and GRASP Tool

Slides:



Advertisements
Similar presentations
JCAHO EXPECTATIONS FOR PRIMARY STROKE CENTER
Advertisements

Atrial Fibrillation Cardiovascular ISCEE 26th October 2010.
Poole AF/ A Flutter Clinic 2011 Diane Bruce Consultant Cardiologist PHNHSFT.
New Atrial Fibrillation/Flutter Pathway and GRASP Tool
1 GRASP-AF Audit - Intro 8 th July 2010 Mark Gregory.
Emergency/Urgent Referral* (3) -Pt acutely unwell with palpitations -Pt with haemodyanically unstable acute onset AF -2 nd /3 rd heart block -Exercise.
ATRIAL FIBRILLATION.
Atrial Fibrillation Service
AF and the New Oral Anti-Coagulants
Management of Atrial Fibrillation in Primary Care Dr Matthew Fay Westcliffe Medical Practice Shipley Westcliffe Cardiology Service.
National Service Frameworks Dr Stephen Newell February 2002.
Atrial fibrillation Cardiology #2 Gimadeeva A.D..
Widimsky P, Tousek P, Rokyta R, et al. Charles University Prague, CZ PRAGUE-7 Study (Hot Lines presenter)
The Internists Approach to Atrial Fibrillation: A Simple Strategy for a Complex Problem Peter Holzberger, MD 12/4/03.
Leadership. Knowledge. Community. Canadian Cardiovascular Society Antiplatelet Guidelines COMBINATION WARFARIN + ASA THERAPY WHEN: TO USE, TO CONSIDER,
Stroke Mark Sudlow Consultant and Senior Lecturer
Atrial fibrillation.
Project Objective To enhance the system of care for atrial fibrillation that not only reduces system costs, but improves the experiences of both patients.
CLINICAL CASES.
Stroke prevention in atrial fibrillation
AF and NOACs An UPDATE JULY 2014
Atrial fibrillation wavelets propagating in different directions disorganised atrial depolarisation without effective atrial contraction f waves
Arrhythmias: The Good, the Bad and the Ugly
Atrial Fibrillation Steve McGlynn
Atrial Fibrillation Steve McGlynn Specialist Principal Pharmacist (Cardiology), Greater Glasgow and Clyde Honorary Clinical Lecture, University of Strathclyde.
Cardioversion of Atrial Fibrillation Clinical Issues Christopher Granger, MD Director, Cardiac Care Unit Duke University Medical Center December 2007.
Atrial Fibrillation. Statistics 1.5% of people over 65 have AF 1.5% of people over 65 have AF 5x increased risk of stroke 5x increased risk of stroke.
INTERVENTIONAL TREATMENT OF ATRIAL FIBRILLATION St. Mary’s Hospital February – August 2007.
Clinical Title Date Jaret Tyler, MD Clinical Cardiac Electrophysiologist Assistant Professor of Medicine Ohio State’s Heart and Vascular Center Atrial.
Treating Atrial Fibrillation Richard Schilling St Bartholomew's Hospital, Queen Mary’s University of London.
Samer Nasr, M.D. Mount Lebanon Hospital..  Lone atrial fibrillation:  Younger than 60 years old.  No clinical or echo evidence of cardiopulmonary.
Cardiac Arrhythmias in Coronary Heart Disease SIGN 94.
Dr Avinash Haridas Pillai
West Herts Cardiology Arrhythmia Management Dr John Bayliss FRCP Consultant Cardiologist 17 Sept 2008.
Atrial Fibrillation Dr Nidhi Bhargava 8/10/13.
Atrial Fibrillation Rate or rhythm control? Who should be anticoagulated? Other treatment strategies.
Atrial Fibrillation Andreas Stein Robert Smith, M.D. August 11, 2003.
Atrial Fibrillation Current Management Strategies.
Specialized Atrial Fibrillation Clinic reduces cardiovascular morbidity and mortality in patients with atrial fibrillation Jeroen ML Hendriks, MSc Robert.
1 EFFECT STUDY 2 EFFECT STUDY  Set national cardiac care benchmarks for hospitals to work towards 
Cardiology Clinical Assessment & Treatment Service …coming soon!
Treatment of Atrial Fibrillation M Samson – PGY-2 Riverside Campus July 17, 2015 Academic Day.
Նախասրտերի շողացում. դեղորայքային մարտավարությունը։ Ռիթմի և հաճախության հսկողությունը։ Ասիմպտոմատիկ շողացումով հիվանդներ Պրոֆ. Հ. Ս. Սիսակյան ԵՊԲՀ, Անհետաձգելի.
CHADS 2 -> CHA 2 DS 2 VASc. CHA2DS2-VASc Risk Score CHF or LVEF < 40% 1 Hypertension1 Age > 752 Diabetes1 Stroke/TIA/ Thromboembolism 2 Vascular Disease.
CHADS, SHMADS: What’s All This About Anticoagulation? COPYRIGHT © 2016, ALL RIGHTS RESERVED From the Publishers of.
Rhythm and Rate Control for Atrial Fibrillation Tom Wallace, MD Cardiac Electrophysiology CHI St. Vincent Heart Clinic Arkansas.
The Case for Rate Control: In the Management of Atrial Fibrillation Charles W. Clogston, M.D. Cardiologist CHI St. Vincent Heart Clinic Arkansas April.
A. Marc Gillinov, MD For the Cardiothoracic Surgical Trials Network (CTSN) ACC April 2016 RATE VERSUS RHYTHM CONTROL FOR ATRIAL FIBRILLATION AFTER CARDIAC.
Palpitations & Atrial Fibrillation Dr Mehul B Dhinoja, Consultant Cardiologist & Electrophysiologist BMI The London Independent Hospital.
Antithrombotic Therapy in Atrial Fibrillation Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy and Prevention of Thrombosis,
Warfarin PSD/HOF001/GB/DC/Rev013 Issued : Review interval:12 months This document may be reviewed and reissued electronically without notice.
26 th February "This SPAF Integrated Care Clinic Programme is funded by Bayer HealthCare as a service to medicine and delivered by Apodi Ltd" Patient.
Atrial Fibrillation: An old age problem PCCS Village Hotel 18 th May 2011.
IN THE NAME OFGODIN THE NAME OFGOD SVTS.SAYAH.  All cardiac tachyarrhythmias are produced by: 1/disorders of impulse initiation :automatic 2/abnormalities.
Stroke Local Pharmacy Group meeting 7 th May 2013 Dr. Lucy Sykes.
Stoke On Trent CCG – Atrial Fibrillation Service AF Nurse in GP Practice Interfacing Primary and Secondary Care for AF Stroke Prevention Jodie Williams.
Clinical pathway for people with atrial fibrillation or at risk of atrial fibrillation Dr Ruth Chambers OBE LTC Priority Lead, West Midlands Academic Health.
Prevention of thromboembolism in AF ACC/AHA/ESC Guidelines Jin-Bae Kim, MD, PhD Arrhythmia Service, Division of Cardiology Cardiovascular Center, Kyung.
ResultsIntroduction Atrial Fibrillation (AF) affects 1.2% 1 of the population and 10% of those over the age of 75 2 It is the commonest arrhythmia in primary.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. Benefit of Anticoagulation Unlikely in Patients With Atrial.
Digoxin And Mortality in Patients With Atrial Fibrillation With and Without Heart Failure: Does Serum Digoxin Concentration Matter? Renato D. Lopes, MD,
Atrial Fibrillation: When Should You Consider Ablation?
Antithrombotic Therapy in Atrial Fibrillation
Quality of Referrals Guideline Congruence of referrals to TIAMS clinic
The Atrial Fibrillation Clinic in Llanelli
Atrial fibrillation (AF) and flutter
Fibrillazione atriale
West Essex Frailty Pathway: Heart Failure
Atrial Fibrillation, AntiCoagulation
NICE 2014 Check pulse in patients presenting with:
Presentation transcript:

New Atrial Fibrillation/Flutter Pathway and GRASP Tool Kay Elliott Arrhythmia Nurse Specialist Dorset County Hospital NHS Foundation Trust

NEW ONSET ATRIAL FIBRILLATION/FLUTTER New Onset Atrial Fibrillation or Flutter Is the patient acutely unwell? Yes No Admit to hospital Rate or Rhythm control strategy initiated and discharged back to primary care with follow-up/onward referrals if required. Patients requiring DC Cardioversion referred to AF/Flutter Clinic See next slide Acute breathlessness/chest pain High risk of deterioration; fast ventricular rate +/- age, co-morbidities Bradycardia/syncopal episodes

BOX A: CHADS–VASc Scoring Primary Care Initiate appropriate stroke/TIA prophylaxis according to CHADS–VASc score (BOX A) and Initiate appropriate rate control (BOX B)     BOX A: CHADS–VASc Scoring Risk Factor Point Heart Failure/LV Dysfunction 1 Hypertension 1 Aged > 75 2 Diabetes mellitus 1 Stroke / TIA 2 Vascular disease 1 Age 65-74 1 Female 1 CHADS–VASc Result: 0 = Aspirin 75mg – 325mg daily or no antithrombotic therapy (preference for no therapy) 1 = Either OAC or aspirin (preference for OAC rather than aspirin) > 2 = OAC recommended Box B: Rate control First Line: Beta-blocker (e.g. Bisoprolol) or a rate limiting calcium antagonist (e.g. Diltiazem), if beta-blocker contraindicated Second Line: Digoxin – additional to optimise rate control, where required. As monotherapy only in predominantly sedentary patients. NEED FOR CLOSER MONITORING RATE CONTROL, INITIATION OF WARFARIN CONTROL IF CHADS2 = 2 OR ABOVE NO NEED TO DO CHADSVASC C – heart failure H – hypertension A - > 75 years D – Diabetes S – Stroke/TIA – 2 points    

(Form attached. Also available on the intranet Paroxysmal NEED FURTHER ADVICE? ARRHYTHMIA NURSE: 01305 254920   Persistent Fax Dorset County Hospital intranet or by contacting BHF Arrhythmia Nurse) referral to Rapid Access Atrial Fibrillation/Flutter Clinic. (Form attached. Also available on the intranet Refer to cardiology team: referral letter or choose and book Cardiologist Appropriate strategy initiated with onward plan/referrals made. Patients requiring DC Cardioversion referred to AF/Flutter Clinic Rapid Access Atrial Fibrillation/Flutter Clinic ECHO AND ECG BHF ARRHYTHMIA NURSE CLINIC: Review history, symptoms, test and examination results Patient education Agree treatment plan: Rhythm or Rate control Arrange ongoing follow-up, where required Referral to cardiology clinic if other cardiac issues identified

  Rhythm Control Rate Control Arrhythmia Nurse Specialist; arrange DC Cardioversion and/or, if indicated: Refer to electrophysiology centre for ablation Manage long-term warfarin and rate-control – Primary Care

Prepare for DC Cardioversion: DC Cardioversion – DAY SURGERY UNIT Weekly INR (Target 2.5-3.0), must have INR >2.0 for four full weeks prior to DC Cardioversion   DC Cardioversion – DAY SURGERY UNIT Procedure and review of medications/onward management plan (Arrhythmia Nurse and Cardiology Specialist Registrar) pre discharge 4 Weeks post procedure: Follow-Up with Arrhythmia Nurse Is the Patient in Sinus Rhythm and are their symptoms improved/satisfactory? Yes No Depending on clinical indications and patient preference either: Re-attempt DC Cardioversion with additional AA cover (amiodarone) Refer for ablation Rate control/Warfarin - (primary Care) Refer to Cardiologist if patient has ongoing symptoms or complications 6 Months post procedure: Follow-Up with Arrhythmia Nurse Is the Patient in Sinus Rhythm and are their symptoms improved/satisfactory? Cont...

6 Months post procedure: Follow-Up with Arrhythmia Nurse Is the Patient in Sinus Rhythm and are their symptoms improved/satisfactory? Yes No Discharge to primary care and patient advised to seek medical attention if symptoms recur Depending on clinical indications and patient preference either: Re-attempt DC Cardioversion with additional AA cover (amiodarone) Refer for ablation Rate control/Warfarin - (primary Care) Refer to Cardiologist if patient has ongoing symptoms or complications Review of echo/CHADSVASC SCORE Anti-coagulation post DC Cardioversion: Maintaining a therapeutic INR during the four weeks post DC Cardioversion is essential for All patients regardless of their CHADS–VASc score. Advice with regards to long-term anti-coagulation is based on patients’ CHADS–VASc score rather than the presence of sinus rhythm/absence of atrial fibrillation/flutter on ECG/Holter.

Over to You – Any Questions?